Location History:
- Padova, IT (2003)
- Padua, IT (2005)
Company Filing History:
Years Active: 2003-2005
Title: Innovator Cristina Comelli: Advancing Cannabinoid Research
Introduction
Cristina Comelli is an accomplished inventor based in Padua, Italy, known for her contributions to cannabinoid research. With two patents to her name, her work focuses on novel therapeutic approaches utilizing cannabinoid receptors to address various health conditions.
Latest Patents
Cristina Comelli's latest inventions include two significant patents. The first patent, titled "Covalent derivatives of alkanolamides of monocarboxylic and dicarboxylic acids functionally active on the CB2 cannabinoid receptor," involves novel covalent derivatives that can act as agonists of the CB2 receptor. This innovation holds potential for use as drugs in treating conditions responsive to receptor stimulation and co-stimulation.
The second patent, "Pharmaceutical compositions containing N-palmitoylethanolamide and use thereof in the veterinary field," presents a method for treating eosinophilic granuloma in felines. It includes a pharmaceutical composition containing N-palmitoylethanolamide, coupled with a specific preparation process for this composition.
Career Highlights
Cristina Comelli has made significant strides in her career, particularly through her work with Innovet Italia S.r.l. Her innovative research and inventions reflect a deep understanding of cannabinoid pharmacology and its applications in both human and veterinary medicine.
Collaborations
Throughout her career, Cristina has collaborated with esteemed colleagues, including Maria Federica Della Valle and Francesco Della Valle. These collaborative efforts have enhanced her research outputs and fostered advancements in cannabinoid therapies.
Conclusion
Cristina Comelli exemplifies the spirit of innovation in the field of cannabinoid research. Her patents not only highlight her ingenuity but also promise to contribute to the development of new therapies that may benefit both humans and animals. As the understanding of cannabinoid receptors expands, we look forward to the impact of her contributions in the medical field.